Cargando…
Metabolomics hallmarks OPA1 variants correlating with their in vitro phenotype and predicting clinical severity
Interpretation of variants of uncertain significance is an actual major challenge. We addressed this question on a set of OPA1 missense variants responsible for variable severity of neurological impairments. We used targeted metabolomics to explore the different signatures of OPA1 variants expressed...
Autores principales: | Chao de la Barca, Juan Manuel, Fogazza, Mario, Rugolo, Michela, Chupin, Stéphanie, Del Dotto, Valentina, Ghelli, Anna Maria, Carelli, Valerio, Simard, Gilles, Procaccio, Vincent, Bonneau, Dominique, Lenaers, Guy, Reynier, Pascal, Zanna, Claudia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7254852/ https://www.ncbi.nlm.nih.gov/pubmed/32202296 http://dx.doi.org/10.1093/hmg/ddaa047 |
Ejemplares similares
-
Drug repositioning as a therapeutic strategy for neurodegenerations associated with OPA1 mutations
por: Aleo, Serena J, et al.
Publicado: (2020) -
The Metabolomic Bioenergetic Signature of Opa1-Disrupted Mouse Embryonic Fibroblasts Highlights Aspartate Deficiency
por: Bocca, Cinzia, et al.
Publicado: (2018) -
Autophagy controls the pathogenicity of OPA1 mutations in dominant optic atrophy
por: Kane, Mariame Selma, et al.
Publicado: (2017) -
The Metabolomic Signature of Opa1 Deficiency in Rat Primary Cortical Neurons Shows Aspartate/Glutamate Depletion and Phospholipids Remodeling
por: Chao de la Barca, Juan Manuel, et al.
Publicado: (2019) -
A Data Mining Metabolomics Exploration of Glaucoma
por: Kouassi Nzoughet, Judith, et al.
Publicado: (2020)